spot_img
10.4 C
London
HomeInvestors HealthBrazilian pharma Hypera approached by EMS for acquisition

Brazilian pharma Hypera approached by EMS for acquisition


word M and A made with wood building blocks, concept

Maks_Lab

  • Hypera S.A. (OTCPK:HYPMY) has received takeover interest from fellow Brazilian pharmaceutical company EMS.
  • Brazil Journal, which broke the news, reported that EMS is offering R$30 per share, a ~17% premium to the prior day’s closing price. 
  • The news outlet noted that the Sanchez family, the 100% holder of EMS’s capital, would become the controlling shareholder of the new company. The deal calls for EMS to be incorporated into Hypera. 
  • A source told Brazil Journal that a transaction “has many commercial, research and development, cost structure, manufacturing structure and distribution synergies.”



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here